Clinical Trials Directory

Trials / Completed

CompletedNCT00598585

Use of Sildenafil (Viagra) to Alter Fatigue, Functional Status and Impaired Cerebral Blood Flow in Patients With CFS

Phase 4 Study of the Use of Sildenafil (Viagra) to Alter Fatigue, Functional Status and Impaired Cerebral Blood Flow in Patients With Chronic Fatigue Syndrome.

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
12 (actual)
Sponsor
Charles Drew University of Medicine and Science · Academic / Other
Sex
All
Age
18 Years – 49 Years
Healthy volunteers
Accepted

Summary

Use of Viagra to Alter Symptoms in Patients with Chronic Fatigue Syndrome (CFS)

Detailed description

Use of Sildenafil (Viagra) to Alter Fatigue, Functional Status and Impaired Cerebral Blood Flow in Patients with Chronic Fatigue Syndrome.

Conditions

Interventions

TypeNameDescription
DRUGSildenafil (Viagra)25 mg tid of either Sildenafil(Viagra) for first week. 50 mg tid of either Sildenafil (Viagra) for second week. 100 mg tid of either Sildenafil (Viagra) 3rd,4th, 5th and 6th week of study participation.
DRUGPlaceboPlacebo pills 3X/day for 6 weeks

Timeline

Start date
2002-07-01
Primary completion
2010-12-01
Completion
2010-12-01
First posted
2008-01-22
Last updated
2017-06-27
Results posted
2017-06-27

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00598585. Inclusion in this directory is not an endorsement.